RemedyBio is now supported through funding from the Irish Research Council to investigate patient stratification and therapeutic development using mass scale single cell analysis, in partnership with Dublin City University. This adds to our existing programme, also supported by IRC, in patient-guided immunological studies for the development of cancer therapies.
Related Posts
News
Remedy Biologics is pleased to announce that Dr Colm Galligan has been appointed to its Board of Directors.
karlobrienFebruary 11, 2026
News
Dan Crowley, CEO of RemedyBio, to Speak at the 7th Annual Allogeneic Cell Therapies Summit 2025 in Boston
karlobrienMarch 31, 2025
